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Introduction
Normovolemia is the blood volume of healthy individuals and averages ~75 ml·(kg body weight) -1 (258). The effective circulating blood volume refers to the part of the volume within the arterial system effectively perfusing the tissues (3, 241) and it is regulated by the interplay between the circulatory system and the kidneys (83). Changes in the venomotor tone can increase, or decrease, the capacity of the venous circulation and thereby partially compensate for variations in the effective circulating blood volume. The effective circulating blood volume is assumed to depend mainly on the central blood volume (CBV) , that is, the blood available to the heart. Transition from the supine to the upright posture has little effect on the blood pressure and orthostasis is proposed as the operating set point for human cardiovascular function (65). However, in order to maintain blood pressure during standing, an elevated vascular tone is required (111, 182, 219) . Cardiac output (CO) is reduced by the postural fall in venous return and CBV (21, 167) with the gravitational displacement of blood to the dependent regions of the body (12, 257) . The need for activation of cardiovascular refl exes for circulatory postural adaptation questions whether, in healthy humans, CBV is optimised to support the circulation in the upright position.
A functional defi nition of 'normovolemia' would be the ability to provide the heart with an appropriate CBV, that is cardiac preload (55, 120). However, the usual clinical and hemodynamic parameters are not reliable indices of preload to the heart (28, 210) and an "optimal" volume is neither defi ned nor is it an easily measurable entity. Hypovolemia may be characterised by a reduced preload to the heart, that is with stroke volume and CO becoming dependent on CBV. The reported increase in CO with volume loading is taken to imply that a patient is preload-responsive (28, 210). Conversely, the intravascular volume may be expanded beyond the volume that can provide for a "maximal" CO at rest. By interpolation between hypo-and hypervolemia, normovolemia may be considered as the point in the cardiac preload-output relationship at which CO does not increase further under circumstances where venous return is unimpeded. We reasoned that in the absence of cardiac to a maximal and minimal preload in the same group of subjects have not been identifi ed and the body position that relates to an optimal preload is unknown. The body position that provides the heart with enough volume to establish a maximal CO at rest was evaluated in volunteers exposed to variations in preload as evoked by displacement of the blood volume to and from the chest by passive tilt at various angles between HUT and head-down tilt (HDT). We hypothesised that changes in CBV are refl ected by concurrent changes in S v O 2 and CO, and that for both CO and S v O 2 a maximum is reached during HDT.
The possible appearance of pre-syncopal symptoms during HUT was taken to represent a lower physiologic limit for both variables in healthy humans.
Methods

Subjects
Nine healthy subjects (one female) were studied after informed consent was given. The study was approved by the Ethical Committee of Copenhagen. The subjects (mean age 29 (range 22-39) years, height 183 (170-191) cm and weight 75 (68-82) kg) showed normal levels of physical fi tness without specifi c training. They had no history of orthostatic fainting and used no medication.
Pressure Measurements
Under local anaesthesia (2% lidocaine), a catheter (20 G; internaldiameter:1.0 mm) was placed in the brachial artery (radial artery in one subject) of the non-dominant arm and a balloon-tipped thermodilution catheter (93A-831H-7.5F Baxter Healthcare Corporation, Irvine, CA,USA) was introduced through the left basilic vein under ECG recording. Proper catheter positioning was confi rmed by monitoring the pressure waveform and the catheter lumen was continuously fl ushed with 3 ml isotonic saline per hour. Pressures were measured by Baxter disposable transducers fi xed to the left upper arm at the level of the right atrium. Central venous (CVP), pulmonary artery mean pressure (PAMP), pulmonary capillary wedge pressure (PCWP) and mean arterial pressure (MAP) were all measured as the integral over each beat divided by the corresponding interval. Heart rate (HR) was obtained from the pulse pressure interval.
Cardiac Output
The thermistor signal was connected to a cardiac output computer (COM-2, Baxter-Edwards).
The CO was determined with 10 ml iced 5% glucose solution drawn from a closed automated injectate delivery system (Baxter-Edwards) and injected linearly over ~ 3 seconds using a pneumatic pump (114, 119) . This approach avoids manual heating of the indicator and improves injection time, consistency in injected volume and linearity of the injection rate (114, 179) . Following the passage of the thermodilution curve and after at least 18 seconds, CO was estimated by the COM-2 and analysed with a personal computer via the serial port and an interface box. Finally, the syringe was automatically refi lled. Four consecutive injections were executed at random phases of the respiratory cycle over 2 minutes to minimise the infl uence of ventilation, and CO was expressed as the mean. Each thermodilution curve was visually checked for shape and appearance time before acceptance.
Mixed Venous Oxygen Saturation
Blood samples for S v O 2 and arterial O 2 saturation (S a O 2 ), partial pressures for arterial and mixed venous O 2 and arterial and mixed venous hemoglobin (Hb a and Hb v , respectively) concentrations were taken anaerobically in heparinised syringes and analysed immediately on an OSM3 and ABL-4 apparatus (Radiometer, Copenhagen, Denmark) at 37q C.
Protocol
After an overnight fast, the subjects were instrumented at 09.00 hours in a room with an ambient temperature of 22q C. Following instrumentation, a test run was performed. After supine rest, periods of tilt at various degrees were interspaced with further periods of supine rest to re-establish control values.
Head-down tilt. After 10 min of supine rest, the subjects were tilted passively with shoulder support to a stepwise increasing angle of -5q, -10q and -20q for 10 min each.
Head-up tilt. After a further 10 min of supine rest, a passive 30q HUT was performed in 3 seconds on a table provided with a foot support. The subjects remained in this position for 5 min and were subsequently tilted supine. After another 10 min, the subjects were tilted to 70q in 6 s. The tilt was terminated by returning the subject supine after 60 min, or at the subject's request, or when the systolic blood pressure fell by more than 20 mmHg. Subjects were requested to abstain from movement in order to minimise changes in oxygen consumption (VO 2 ) related to muscle activity. Blood samples were drawn and a series of four thermodilution CO estimates was performed after 5 min in each position of the HDT and HUT 30q, and every 10 min during the sustained HUT 70q.
Data Analysis and Statistical Procedures
Systemic vascular resistance was (MAP-CVP)/CO and pulmonary vascular resistance (PAMP-PCWP)/CO. The VO 2 was the arterial-venous O 2 difference times CO. Values at supine rest prior to 30q HUT were taken as baseline. Apart from CO, data followed a normal distribution and were expressed as mean ± SD. The CO was expressed as median with range. Bonferroni adjustment to control the family-wise Type I error-rate (155). Interdependencies were evaluated by the least square method and a P value < 0.05 was taken to represent a statistical signifi cant difference.
Results
The supine and HDT positions were tolerated well, where 70q HUT evoked syncopal symptoms in four subjects (Figure 1 ). One subject experienced presyncopal symptoms (abdominal discomfort and weakness) without a drop in MAP (92 mmHg) and HR (82 bpm) and was tilted back after 24 min. In three subjects MAP dropped to 42-47 mmHg and HR to 68-87 bpm after 9, 10 and 26 min, respectively, together with the development of presyncopal symptoms. The subjects recovered upon reaching the horizontal position. The median time at 70q HUT was 28 (range 10-66) min allowing for 10 (range 9-14) observations in each subject. Cardiac output and mixed venous oxygen saturation during head-up and head-down tilt in 9 healthy young subjects. O: supine; : head-down tilt; ½:
head-up tilt. In subjects S1, S3, S6 
Head-down Tilt
From supine rest to 20q HDT, MAP decreased from 93 r 9 to 90 r 9 mmHg with no changes in HR (53 ± 10 bpm). In contrast, PCWP (10.2 ± 2.4 to 11.3 ± 2.5 mmHg; P<0.05) and PAMP (14.8 ± 2.5 to 16.3 ± 2.4 mmHg; P<0.05) increased, with CVP (3.8 ± 1.2 to 4.7 ± 0.5 mmHg; P = 0.08) following the same pattern. The Hb a level did not change but the Hb v decreased indicating slight hemodilution ( 
Head-up Tilt
From the supine position to 30q HUT, MAP did not change and CO tended to decrease to 5.3 (3.4-8.1) l·min -1 (P = 0.07) while S v O 2 remained stable at 72.3 ± 3.0% (Figure 2) . From 30q to 70q HUT, CO and S v O 2 decreased to, 5.2 (4.6-7.8) l·min -1 and 66.1 ± 4.4%, respectively.
The MAP did not change but systemic vascular resistance increased (1143 ± 221 to 1317 ± 263 dyne·sec -1 ·cm -5 ; P < 0.0001). During 70º HUT, CVP decreased from 4 ± 2 to 2 ± 2 mmHg, PAMP from 14 ± 3 to 11 ± 4 mmHg and PCWP from 9 ± 3 to 2 ± 3 mmHg. The VO 2 increased to 331 ± 65 ml·min -1 and remained at that level until the subjects were supine. Just prior to tilting the subjects to the supine position, the CO was 4.7 (3.9-5.6) l·min acclimation to microgravity. After a few days in microgravity, blood volume and thus cardiac stroke volume decrease as is the case after prolonged bed rest on earth (299). The fi nding of an elevated vascular resistance in space agrees with the "upright set-point" hypothesis (298). Our study in healthy humans demonstrates that CO, and in turn S v O 2 , do not increase from supine rest to head-down tilt, a condition in which CBV was assumed to be expanded. Conversely, both CO and S v O 2 decreased during HUT and were lower by 1.3 l·min -1 and 10%, respectively, when fainting was imminent. These results suggest that the "optimal volume", defi ned as the circulating blood volume that can provide for a maximal CO (and in turn S v O 2 ), corresponds to the volume that is available to humans in the supine position.
This is perhaps a surprising fi nding as healthy humans spend many hours upright. However, sympathetic tone increases to raise vascular resistance and to maintain blood pressure in the upright position, and it may be considered that the fi lling state should be optimal under the conditions with the lowest sympathetic tone, that is recumbency. The consequent state of CBV level in the upright body position with a lowered CO and S v O 2 , and also a reduction in cerebral blood velocity and regional cerebral tissue oxygenation (89, 150, 213, 293) , can be ameliorated by leg muscle tensing (134, 287) and refl ex vasoconstriction with an increase in venous return and thus CO (65, 96, 252) . These fi ndings appear contrary to the "upright setpoint" hypothesis and point to supine rest as the body position at which resting CO and S v O 2 are maximal on earth (307). re-establish and maintain a blood volume able to provide near normal blood pressure and an adequate CO. On the other hand, deliberately increasing blood volume during surgery may expose patients to a volume overload (120). A "normal" blood volume may be defi ned as the volume of blood contained within a healthy person. Yet the blood volume varies not only with stature and gender, but also with physical activity (244) and it is not known how an average value for the population applies to the individual. Furthermore, the blood volume is not a readily determined variable. We considered that the blood volume is characterised not only by its size but also by its function as preload to the heart.
From the supine to the upright position ~500 ml of blood is immediately pooled in the venous system (255) with a reduction in CBV of about 25% (167, 257). With a postural reduction in CBV, CO decreases and S v O 2 follows CO as a given oxygen uptake has to be extracted from blood exposed to a lower fl ow. During standing, presyncopal symptoms appear when the CBV is reduced by ~30% (167) associated with a decline in HR in response to increased vagal tone, while sympathetic tone to skeletal muscle ceases leading to a reduction in systemic vascular resistance and MAP (9, 149, 232, 288, 289) . Fainting refl ects the decrease in cerebral perfusion (161, 293) . Conversely, we considered a body position for which both CO and S v O 2 would reach maximal values, that is a body position where CO is not limited by the preload to the heart. By tilting the subjects to the head-down position, we found that neither CO nor S v O 2 increased. Thus, in humans 'normovolemia' may be defi ned as the circulating blood volume a healthy subject is provided with during supine rest.
